Lohrmann H P, Lepp K A, Schreml W
J Natl Cancer Inst. 1982 Apr;68(4):541-7.
The reaction pattern of the normal (nonleukemic) human granulopoietic system to single-agent treatment with 5-fluorouracil (FUra) and to a combination of FUra with two nitrosoureas, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU), was studied serially by morphologic and in vitro culture methods. The granulopoietic toxicity of FUra was acute and rapidly (by day 21) reversible. In contrast, the toxicity of the combination regimens was long lasting. Evidence exists that an early toxicity (that of FUra) and a delayed toxicity (that of the nitrosourea) were overlapping. Toxicity of BCNU and MeCCNU was most pronounced at the level of in vitro colony-forming units of the granulopoietic system (G-CFUc). G-CFUc compartments of bone marrow and peripheral blood continued to be reduced in size at the time of recovery of the peripheral blood granulocyte count from nitrosourea-induced toxicity. This finding may be responsible for the cumulative toxicity to the human hematopoietic system that frequently has been observed after repeated administration of nitrosourea compounds.
采用形态学和体外培养方法,对正常(非白血病)人粒细胞生成系统对5-氟尿嘧啶(FUra)单药治疗以及FUra与两种亚硝基脲(1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)和1-(2-氯乙基)-3-(4-甲基环己基)-1-亚硝基脲(MeCCNU))联合治疗的反应模式进行了系列研究。FUra的粒细胞生成毒性是急性的,且迅速(在第21天)可逆。相比之下,联合治疗方案的毒性持续时间长。有证据表明,早期毒性(FUra的毒性)和延迟毒性(亚硝基脲的毒性)相互重叠。BCNU和MeCCNU的毒性在粒细胞生成系统的体外集落形成单位(G-CFUc)水平最为明显。在从亚硝基脲诱导的毒性中恢复外周血粒细胞计数时,骨髓和外周血的G-CFUc区室大小持续减小。这一发现可能是反复给予亚硝基脲化合物后经常观察到的对人类造血系统累积毒性的原因。